ADB launches $9 bn Asia Pacific Vaccine Access Facility (APVAX) for Developing Countries

The Manila-based Asian Development Bank (ADB) has launched an initiative called, the Asia Pacific Vaccine Access Facility (APVAX), for its developing member countries.
Through APVAX, the ADB will offer rapid and equitable support to its developing members, who need financing to procure vaccines as well as offer appropriate plans and knowledge to be able to safely, equitably and efficiently manage and deliver the COVID-19 vaccine.
The bank has allocated USD 9 billion for APVAX.